Herbert Lyerly
Surgery Residency · Duke University Hospital
Credentials: · ·
History
2024–Present
1979–1983
Research
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Journal of Translational Medicine · 2005 · Last of 13 authors · 923 citations
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
Science · 1991 · 817 citations
The Lancet · 1986 · 785 citations
148 papers · 3 as a fellow
17 papers · 14 as a fellow
- AA
12 papers
12 papers · 8 as a resident
- NS
12 papers
11 papers · 1 as a fellow
9 papers · 6 as a resident
- KB
7 papers
Grants
- 2002–2022
Translational Research in Surgical Oncology
National Cancer Institute · T32
Contact PI · $5.2M · Duke University
- 2004–2015
Clinical Oncology Research Career Development Program
National Cancer Institute · K12
Contact PI · $8M · Duke University
- 1976–2014
Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Contact PI · $70.6M · Duke University
- 1999–2011
Immunotherapy with High Frequency, CEA Specific T Cells
National Cancer Institute · P01
Contact PI · $14.6M · Duke University
Clinical trials
- 2003–2006
Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Study chair · Completed · Phase 1
Duke University
- 2002–2007
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Study chair · Completed · Phase 1
Michael Morse, MD
- 1998–2003
Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
Study chair · Completed · Phase 1, Phase 2
Duke Cancer Institute
- 1998–2002
Immunotherapy in Treating Patients With Metastatic Breast Cancer
Study chair · Terminated · Phase 1, Phase 2
Duke University